semaglutide and cardiovascular Outcomes in Patients with Type 2 Diabetes Cardiovascular outcomes of semaglutide and

Expected Weight-Loss Results Weight loss with GLP-1 medications is steady and progressive rather than sudden

Address: 3rd Floor (Lift-2), 122 Priyangon Faizunnessa Business Centre, Kakrail Rd, Dhaka 1217 Phone: 09613-002003

Common Side Effects Include: Nausea Vomiting Diarrhea Constipation Loss of appetite Fatigue For dialysis patients, these symptoms can increase the risk of: Dehydration Malnutrition Muscle loss Electrolyte imbalance Low blood pressure during treatment Because dialysis already places stress on fluid balance, vomiting or poor oral intake can become serious quickly

This is because excess fat mass doesnt increase protein needs the way muscle mass does